Abbreviations: ECM: extracellular matrix; PAK: p21-activated kinase; CRIB: Cdc42/Rac-interacting binding domain; GEF: guanine nucleotide exchange factor.
Directional and persistent cell migration is essential for a large number of physiological processes in multicellular organisms. In the embryo, complex patterns of cell migration are involved in proper tissue formation. In the adult, the migration of leukocytes into damaged or infected tissue is crucial for an effective immune response, and migration of keratinocytes and dermal fibroblasts are key aspects of wound healing. In addition, the etiology of a wide variety of diseases features aberrant cell migration, ranging from metastases in cancer to autoimmune syndromes. 1 Motile cells possess the ability to migrate in all directions, and only in response to chemoattractants such as growth factors and extracellular matrix (ECM) proteins do cells polarize. 2, 3 Extracellular stimuli cause the formation of a polarized, branched-actin lamellipodium that is responsible for protrusion at the leading edge of a motile cell. 4 The current challenge is in understanding how cell polarity is achieved, despite the diffuse distribution of the molecules involved. ECM receptors, such as integrins and syndecan-4, are expressed across the surface of the cell and signal to the cytoskeletal regulator, Rac1, which is also diffusely distributed. The roles of such molecules in directing in vivo migration in vertebrates is exemplified by the fibroblast migration defects, and consequently wound healing defects, caused by disrupting syndecan-4 or Rac1 in mice. [5] [6] [7] However, until recently, mechanisms by which cells distinguish between ECM receptor engagement at the front and sides of the cell have been lacking, as have explanations of how Rac1 is redistributed from the sides to the front of a migrating cell, and how the cytoskeleton feeds back into Rac1 regulation. In a recent paper from our laboratory, we identified the actin-binding protein, coronin-1C, as a key regulator of Rac1 trafficking that was necessary for Rac1 activation at the leading edge. 8 Coronin-1C is a multi-domain protein, comprising a b-propeller, which may act as a protein scaffold, includes an actin binding site, and is required for membrane localization; 9 a unique linker region that contains a second actin-binding site; 10 and a C-terminal coiled-coil which is responsible for formation of homotrimers and binds to both the cell membrane 11 and the actin-related protein, Arp2/3 12 (Fig. 1A) . We identified 2 further features: a binding site for GDP-Rac1 in the propeller domain and an RCC2-binding site in the unique linker region. 8 The interaction with RCC2 is particularly significant as we also found that RCC2, which associates with adhesion complexes, 13 acts as a competitive inhibitor of Rac1 activation. 8 Together, RCC2 and coronin-1C were found to mediate the redistribution and modulate the activation of Rac1, thus focusing Rac1 activation into a single protrusive membrane in response to fibronectin stimulation. It has been proposed that binding of type I coronins to Arp2/3 modulates actin branching in a concentration-dependent manner and may be responsible for focusing regions of membrane protrusion. 9 The ability of coronin-1C to selectively target Rac1 to similar regions suggests that coronin-1C plays a major role in migration guidance.
To better understand the nature of the coronin-1C/Rac1 interaction, molecular docking was used to generate a model that would allow us to predict key interacting residues. In the absence of a coronin-1C crystal structure, a homology model of this protein was generated from the coronin-1A structure 14 and used in combination with the available Rac1-GDP crystal structure 15 in a series of docking simulations. A single high probability Rac1-GDP/coronin-1C complex model was identified (Fig. 1B) . Binding was predominantly via complementary electrostatics and hydrogen bonding between the face of the coronin-1C propeller and the switch I and switch II regions of Rac1. The key binding site involved the electrostatic interactions of Arg31 of coronin-1C (Fig. 1B,  green) with the carboxyl oxygens of Asp38 and hydroxyl group of Thr35 of Rac1. The importance of these interactions have been verified by mutagenesis. 8 Interestingly, it has been reported that Dictyostelium discoideum coronin contains a partially conserved Cdc42-Rac1-interactive binding (CRIB) domain that may also mediate interaction with Rac1. 16 However, although human coronin-1C contains the critical Pro122 and His129 residues, the rest of the consensus motif is more poorly conserved (Fig. 1C) . The proline and histidine are partially buried (Fig. 1B, magenta) and do not overlap with the verified Rac1-binding motif. Thus it appears that the Rac1-binding CRIB motif is not conserved between Dictyostelium coronin and human coronin-1C. Furthermore, the Rac1-binding Arg31 is not conserved in human coronin-1A. The different effects of coronin-1C and coronin-1A on Rac1 are manifested at the functional level with coronin-1A delivering Rac1 to the plasma membrane, and coronin-1C facilitating release. 8, 17 The interactions of coronin-1C with both Rac1 and Arp2/3 suggest a possibility of coordination between cytoskeletal regulators and the cytoskeleton itself, however the position of the Rac1-binding site raises questions about possible competition with actin binding. Actin binding by the coronin-1C propeller is mediated by Arg28, which is conserved between type I coronins (Fig. 2D, blue) . 10 Although the actin and Rac1-binding sites do not directly overlap, our structural model shows that proximity of the sites would prevent simultaneous binding of actin and Rac1 to the coronin-1C propeller. However, such competition would not necessarily preclude simultaneous association with actin and Rac1, as uniquely among coronins, coronin-1C contains a second actin-binding motif within the linker region of the tail domain. 10 The relationship between binding sites caused us to examine the localization of coronin-1C, actin and Rac1 within the cell. It is noticeable that the previously reported accumulation of coronin-1C along the lateral edges of cells coincides with bundled actin stress fibers (2A), which is not typically where Rac1 would be expected to localize. GFP-coronin-1C was also detected in small vesicles in the perinuclear region of the cell, where it colocalised with actin puncta ( Fig. 2A, zoom) . This distribution agreed with previous observations that coronins colocalise with filamentous actin, and that actin-binding is central to the function of coronins. 9, 18 Although endogenous Rac1 is diffusely distributed in the cell, coronin-1C/Rac1 positive puncta can be observed, and when Rac1 and coronin-1C are overexpressed, numerous, large costained vesicles are formed (Fig. 2B) . Formation of these vesicles is consistent with our recent report that knockdown of coronin-1C caused Rac1 to become trapped in the detergent-insoluble membrane at the sides of the cell, 8 indicating that coronin-1C plays a role in Rac1 trafficking. The immobilization of Rac1 was demonstrated to be dependent on membrane-association, rather that association with the actin cytoskeleton, as diffusion of a CAAX box-mutant Rac1, which is unable to associate with the cell membrane, was unaffected by knockdown of coronin-1C.
The model of coronin-1C-mediated Rac1 trafficking led us to examine the role of canonical endocytic and trafficking molecules in the process. Dynamin is one of the major mediators of eukaryotic endocytosis, and is responsible for promoting fission of tubulating membrane into newly formed endocytic vesicles. 19 To test release of Rac1 from insoluble membrane microdomains, cells were fractionated into detergent-soluble and detergent-insoluble fractions. In control cells, Rac1 was detected predominantly in detergent- soluble membrane, but shifted to the insoluble fraction upon knockdown of coronin-1C (Fig. 2C) . By contrast, depletion of dynamin-2 (Dnm2, the dynamin isoform expressed in fibroblasts) did not lead to Rac1 being trapped in the detergent-insoluble fraction (Fig. 2D) , demonstrating that coronin-1C-mediated release of Rac1 is dynamin independent. To further investigate whether coronin-1C directs Rac1 through a canonical trafficking pathway, we examined the localization of coronin-1C in cells stably expressing GFP-Rab4, -Rab5, -Rab11 and Rab-7 (Fig. 2E) . Rab positive vesicles are less punctate than coronin-1C-stained vesicles, and there was no apparent overlap in localization. Collectively these experiments demonstrate that coronin-1C does not direct Rac1 through the dynamin-dependent, Rabmediated pathway that is responsible for most endocytosis. The fact that the coronin-1C vesicles co-stain for actin might suggest some form of pinocytic mechanism and this is certainly an area for future investigation. It would also be worth examining whether coronin-1C associates with other trafficking mediators, such as members of the sorting nexin family of proteins, which direct endocytic cargos through a range of trafficking pathways.
A key question is how coronin-1C affects organization of the actin cytoskeleton within the cell. Due to the interaction with the Arp2/3 complex, it would not be surprising if coronins affected actin filament dynamics, although the presence of multiple coronin isoforms introduces redundancy into the system. 9 However, the unique Rac1 and RCC2-binding motifs of coronin-1C would cause us to expect a phenotype in depleted cells, and led us to compare the effects of depleting coronin-1C and inhibiting Rac1. Knockdown of coronin-1C did not affect the formation of actin stress fibers, but did appear to affect the alignment. To analyze the change in cytoskeletal architecture, we divided images into sections and used fast-fourier transformations to fit ellipses to the distribution of fluorescence intensity and measure the angle of maximum intensity in each section, so that the alignment of fibers between multiple sections could be calculated. Coronin-1C-depleted cells exhibited a significantly increased actin alignment compared to control (Fig. 3A-C) . A similar increase in actin alignment was observed when Rac1 was pharmacologically inhibited by EHT 1864 (Fig. 3A and D) or depleted using siRNA (Fig. 3E-G) . The similarity in effects on actin structure implies that deregulation of Rac1 in coronin-1C knockdown cells is the cause, rather than consequence of, cytoskeletal reorganization. If loss of Rac1 signaling were downstream of actin alignment, inhibition of Rac1 would not have the same effect. The change in alignment is important because, given the role of coronins in suppressing actin branches by inhibition of Arp2/3, one might expect fiber alignment to be reduced in coronin-1C-knockdown cells. However, the opposite was observed, suggesting the effect on Rac1 regulation dominates.
To test the hypothesis that Rac1 regulation lies upstream of actin alignment signals, we investigated the effect of cytoskeletal integrity on Rac1 activation. Actin stress fibers can be disassembled by treatment of cells with the Rhokinase inhibitor, Y27632 (Fig. 4A) . In control cells plated on a minimal integrin-binding ligand in the absence of serum, Rac1 could be activated by stimulation with a soluble syndecan-4-binding fragment of fibronectin, thus triggering adhesion-dependent signaling by engaging both fibronectin receptors (Fig. 4B) . Importantly, activation of Rac1 was not dependent on the integrity of stress fibers, as cells treated with the Rho kinase inhibitor Y27632 still activated Rac1 in response to fibronectin (Fig. 4C) . This observation does not rule out the involvement of all actin structures in coronin-1C function, as actin filaments, actin ruffles and actin vesicles were still observed in cells treated with Y27632 (Fig. 4A) . Indeed, the fact that actin-associated vesicles still form may be critical to coronin-1C-dependent Rac1 trafficking. However it does demonstrate that the effects we report on Rac1 regulation in coronin-1C depleted cells are not simply a consequence of a reduction in actin crosslinking, and suggests that the originally described role of coronins in actin crosslinking, and the unique role of coronin-1C in redistributing Rac1 for reactivation are separate. However, the roles of coronin-1C in both regulation of actin branching by Arp2/3 and Rac1 redistribution, which itself regulates Arp2/3 through the WAVE complex, means that further investigation in this area is needed. The roles of Arp2/3 in lamellipodial extension and migration guidance, 20 combined with the importance of intermediate Rac1 activity for persistent migration 21 would make such investigations fruitful. 
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Other questions surrounding the process of coronin-1C-dependent Rac1 trafficking are the mechanisms by which Rac1 is released for activation and signaling. We have reported that coronin-1C and the sequestering molecule, RCC2, compete for the same binding site on Rac1 and that the RCC2 interaction has higher affinity. 8 Indeed, it was found that trafficking of Rac1 from RCC2-containing protrusive membranes was unaffected by coronin-1C knockdown, and that only at lateral membranes was Rac1 mobility affected by coronin-1C expression. As coronin-1C is found throughout the plasma membrane as well as actin-associated vesicles, it is probable that coronin-1C mediated release is directional, and is responsible for movement of Rac1 from lateral to protrusive membrane (Fig. 5) . Such a model is complemented by the poor affinity of coronin-1C for GTP-bound Rac1, which would cause movement of inactive Rac1 from lateral membranes, but not active Rac1 from protrusions. This hypothesis was supported by the observation that tagged Rac1 redistributed from lateral to protrusive membrane in control cells, but failed to do so upon knockdown of coronin-1C. We also reported that RCC2 could be out-competed by high concentrations of active guanine exchange factor (GEF). It follows from these results that local concentrations of RCC2, Coro1C and GEFs are important in determining areas of local Rac1 activation.
In our previous manuscript, we used the well-characterized Rac1-GEF Trio to model the competition between RCC2 and a GEF. However, the actual GEF responsible for this process in normal physiology is unknown, and remains a prominent question moving this research forward. In addition, the factors which determine relative concentrations of exchange factors at different regions of the membrane remain poorly characterized. A study by Goryachev and Pokhilko 22 acknowledged the importance of maintaining appropriate concentrations of GTPase regulators at the cell membrane, and the likelihood that efficient GDP-GTP cycling can only take place within dense protein complexes. It is tempting to hypothesize that certain areas of the cell membrane are predisposed toward activation, although this study did not examine the role of additional matrix receptors in determining dynamics of Rac1 activation. For example, it may be that one fibronectin receptor, a5b1 integrin, 'primes' the focal adhesion for activation of Rac1 by a second fibronectin receptor, syndecan-4 (Fig. 5) . If this is the case, then understanding the complexes formed between transmembrane receptors and the activation, sequestration and trafficking regulators of small GTPases will be the key to understanding migration guidance.
Methods

Cell culture and RNAi knockdown
The generation of immortalized MEFs has been described previously. 5 To allow expression of the large T antigen, MEFs were cultured at 33 C in DME, 10% FBS, 4.5 g/l glucose, 2 mM L-glutamine and 20 U/ml IFNg (Sigma, I4777). Telomerase-immortalized human fibroblasts were cultured at 37 C in DME, 15% foetal bovine serum, 4.5 g/l glucose, 25 mM HEPES and 2 mM L-glutamine. Where appropriate, fibroblasts were transfected with pDsRed-Rac1 and GFP-Coro1C using Fugene HD (Promega, E2311). HeLa cells stably expressing GFP-Rab4, Rab5, Rab7 or Rab11 were a gift from Professor Pete Cullen, University of Bristol, and were cultured at 37 C in DME, 10% foetal bovine serum, 4.5 g/l glucose and 2 mM L-glutamine. siRNA duplexes with ON TARGET TM modification for enhanced specificity were purchased from Dharmacon (Thermo Fisher Scientific). Sequences targeted the sense strand of mouse Coro1C (CCGUUGAAUUAAUUACGUA) or Rac1 (AGACGGAGCU-GUUGGUAAAUU), or human Coro1C (GCACAAGACUGGUCGAAUU). For knockdown, 160 pmol of targeted or control oligo was transfected into a 90% confluent 25-cm 2 flask using Dharmafect2 reagent (Dharmacon, T-2002-03). After 18 hours, the cells were passaged and cultured for 2 days before transfecting again to ensure substantial knockdown. Cells were passaged 18 hours after the second round of transfection and used within 2-3 days. Expression of target proteins in comparison with mock-transfected cells was tested by Western blotting.
Immunofluorescence 13-mm diameter glass coverslips were coated with 10 mg/ml fibronectin (Sigma, F1141) in Dulbecco's PBS containing calcium and magnesium (Sigma, D8662), and blocked with 10 mg/ml heat-denatured BSA for 30 minutes at room temperature. Cells were spread for 4 hours at 1.25 £ 10 4 cells per coverslip in DME, 10% FBS, 4.5 g/l glucose, 25 mM HEPES, and then treated with 50 mM EHT1864 if appropriate. Spread cells were fixed with 4% (w/v) paraformaldehyde, permeabilized with 0.5% (w/v) TrX diluted in PBS, and blocked with 3% (w/v) BSA in PBS. Fixed cells were stained with phalloidin (Sigma, 65906), mounted in Prolong Ò Antifade (Invitrogen, P36934) and photographed on a Leica SP5-II confocal laser scanning microscope using a 100x, NA 1.4 PlanApo objective. Maximum projection images were compiled, bandpass filtered, and analyzed using ImageJ software.
Fiber Alignment Analysis
Alignment is measured using the dot product. Each straight segment of the track defines a vector v i , which may be compared to all the other segments of the track. The value of the dot product d ij between vectors v i and v j is Cell fractionation and Rac1 activity Tissue culture-treated plastic dishes (Corning BV, 430167) were coated with 20 mg/ml recombinant fibronectin polypeptide encompassing type III repeats 6-10 that comprises the a 5 b 1 -integrin ligand (50K). 5 To prevent de novo synthesis of ECM and other syndecan-4 ligands, MEFs were pretreated with 25 mg/ml cycloheximide (Sigma, C7698) for 2 hours and spread for 2 hours in DME, 4.5 g/l glucose, 25 mM HEPES, 25 mg/ml cycloheximide. Where appropriate, spread cells were treated 10 mM Rho Kinase inhibitor, Y27632 (Millipore, 688000) or 10 mg/ml recombinant fibronectin polypeptide encompassing type III repeats 12-14 that comprises the syndecan-4 ligand (H/0). 5 For cell fractionation, detergent-resistant membrane and cytoskeletal components were separated by cetrifugation following lysis with 20 mM HEPES (pH 7.4), 10% (v/v) glycerol, 140 mM NaCl, 1% (v/v) Nonidet P-40, 4 mM EGTA, 4 mM EDTA. For GTPase signaling assays, active Rac1 was precipitated from cell lysates using GST-PAK-CRIB as bait.
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